9-Iodononanoic acid | 88019-90-3

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 9-Iodononanoic acid
• CAS: 88019-90-3
• 化学式: C₉H₁₇IO₂
• 分子量: 284.13
• InChiKey: KNTGUFLHSQVAHE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  12
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  9-Iodononanoic acid 、 碘化钠 生成 9-(131I)iodanylnonanoic acid
  参考文献：
  名称：

  CTAHKO, V. I.;BRATTSEV, V. A.;DANILOVA, G. N.;SEDOV, V. V.;MATVEEV, V. A.+

  摘要：

  DOI：

文献信息

• Omega-(2-oxo-benzimidazolinyl)-alkanoic acid derivatives, process for producing the same and pharmaceutical compounds containing the same
  申请人：A. Nattermann & Cie. GmbH

  公开号：EP0051827A1

  公开（公告）日：1982-05-19

  The present invention refers to new ω-(2-oxo- benzazolinyl)-alkanoic acids as well as salts and esters thereof having the general formula I process for producing the same and pharmaceutical preparations containing the same.

  本发明涉及具有通式 I 的新ω-(2-氧代-苯并唑啉基)-烷酸及其盐和酯。 以及含有这些物质的药物制剂。
• N-benzoyl-alpha-anilino alkane carboxylic acids, salts and esters thereof, process for producing the same and pharmaceutical preparations containing the same
  申请人：A. Nattermann & Cie. GmbH

  公开号：EP0051828A1

  公开（公告）日：1982-05-19

  The present invention refers to N-Benzoyl-ω-anilinoalkane carboxylic acids, their esters and salts of the general formula having thrombocyte aggregation inhibiting effectiveness, processes for producing the same and drugs containing the same.

  本发明涉及通式为 N-苯甲酰基-ω-苯胺基烷烃羧酸、其酯类和盐类，具有血小板聚集抑制功效，以及生产这些物质的工艺和含有这些物质的药物。 具有血小板聚集抑制功效的 N-苯甲酰基-ω-苯胺烷烃羧酸、其酯和盐，以及生产这些物质的工艺和含有这些物质的药物。
• N-substituted omega-(2-oxo-4-imidazolin-1-yl) alcanoic acids, salts and esters thereof, process for producing the same and these active agents containing pharmaceutical compounds
  申请人：A. Nattermann & Cie. GmbH

  公开号：EP0051829A1

  公开（公告）日：1982-05-19

  the present invention refers to new N-substituted ω-(2-oxo-4-imidazolin-1-yl) alcanoic acids as well as salts and esters thereof having the general formula I process for producing the same and these active agents containing pharmaceutical compounds.

  本发明是指新的 N-取代ω-(2-氧代-4-咪唑啉-1-基)辛酸及其具有通式 I 的盐和酯，以及这些含有药物活性剂的化合物的生产工艺。
• Azido-substituted fatty acid analog enzyme substrates
  申请人：WASHINGTON UNIVERSITY

  公开号：EP0480901A1

  公开（公告）日：1992-04-15

  Azido-substituted fatty acid analogs which are useful in the fatty acid acylation of peptides and proteins and as antiviral agents are disclosed having the following chemical structure:         Z - (CH₂)xCOOR wherein    Z = azido, tetrazolyl or triazolyl    R = H or C₁-C₈ alkyl, and    x = 8-12 or structure (I) as defined above and wherein a methylene group from carbon position 3 to within 2 carbons of Z is replaced with oxygen or sulfur.

  已公开的叠氮取代脂肪酸类似物具有以下化学结构，可用于肽和蛋白质的脂肪酸酰化，也可用作抗病毒剂： Z - (CH₂)xCOOR 其中 Z = 叠氮基、四唑基或三唑基 R = H 或 C₁-C₈ 烷基，以及 x = 8-12 或如上定义的结构(I)，其中 Z 的第 3 碳位至 2 碳位内的亚甲基被氧或硫取代。
• Process for preparing hydroxycarboxylic acids
  申请人：UNILEVER PLC

  公开号：EP0711746A1

  公开（公告）日：1996-05-15

  A new synthesis of ω-hydroxy acids, which employs commercially available starting materials and lowers the cost of production. The process involves coupling a fatty acyl group by enamine chemistry, followed by a ring expansion and selective reduction of ketoacid.

  一种新的ω-羟基酸合成法，它采用了市场上可买到的起始原料，并降低了生产成本。该工艺包括用烯胺化学方法偶联脂肪酰基，然后进行扩环和选择性还原酮酸。